Search - tctmd.com

Displaying 21 - 40 of 78

Sort: Relevancy | Date

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News ISC 2024

Assisted Reproductive Technology Linked to Higher Stroke Risk

Todd Neale

February 07, 2024

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

News Daily News

Reduced EF Evident in Some Elite Endurance Athletes

Michael O'Riordan

December 21, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News HFSA 2023

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

L.A. McKeown

October 12, 2023

News Daily News

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

Shelley Wood

July 19, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

Journal Series Explores How Eroding Abortion Access Impacts the HF Community

Todd Neale

June 15, 2023

News Daily News

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Shelley Wood

March 31, 2023

News Featured Fellow

Daniel Shpilsky, MD

Yael L. Maxwell

March 31, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

Advertisement

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Assisted Reproductive Technology Linked to Higher Stroke Risk

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

Reduced EF Evident in Some Elite Endurance Athletes

November 2023 News Roundup

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Journal Series Explores How Eroding Abortion Access Impacts the HF Community

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Daniel Shpilsky, MD

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Top Endovascular News of 2022

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

FLASH: More Data to Support Mechanical Thrombectomy in PE

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content